Theriva Biologics Inc. (NYSE AMERICAN: TOVX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT THERIVA BIOLOGICS INC.

Theriva Biologics Inc. (NYSE AMERICAN: TOVX)
Listen to this Section


$0.28
-0.0108 ( -3.75% ) 13.8K

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Market Data


Open $0.28
Previous Close $0.29
Volume 13.8K
Market Cap $13.13M
Day Range $0.28 - $0.29
52 Week Range $0.16 - $0.86
Shares Outstanding 45.89M
Change % -3.75%
Net Change ▼ -0.0108
Insider Ownership N/A
Exchange NYSE AMERICAN
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year1993
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -1,030,000.00

Date Type Amount Purchased Purchaser
2023-12-15 Sale -110000.00 MONAHAN JOHN J
2023-12-15 Sale -110000.00 Kraws Jeffrey J
2023-12-15 Sale -110000.00 Wolf Jeffrey Alan
2023-12-15 Sale -700000.00 SHALLCROSS STEVEN A

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Oct 06, 2025
8-k 8K-related 12 Oct 02, 2025
8-k 8K-related 13 Sep 04, 2025
10-q Quarterly Reports 73 Aug 11, 2025
8-k 8K-related 14 Aug 11, 2025
ars Annual reports 1 Jul 09, 2025
def Proxies and info statements 21 Jul 09, 2025
8-k 8K-related 12 Jun 25, 2025
8-k 8K-related 14 Jun 20, 2025
8-k 8K-related 14 Jun 02, 2025

Latest News


× Before browsing our site, please accept our cookies policy